OR WAIT null SECS
December 09, 2025
Video
GLP-1 receptor agonists revolutionize treatment in cardiology, offering new hope for heart failure and related conditions beyond weight loss.
December 04, 2025
Article
Catch up with major FDA decisions, critical conference news, and more.
November 29, 2025
O’Donoghue discusses the results of this analysis of the FOURIER trial, highlighting that no limit was found for lowered LDL-C improving MACE risk.
November 27, 2025
O’Donoghue discusses the results of the recent OCEAN(a)-DOSE trial and addresses the implications for Lp(a)-lowering therapies moving forward.
November 25, 2025
Nicholls highlights tirzepatide’s capacity to lower the risk of heart failure mortality, as well as hospitalizations or urgent visits.
November 24, 2025
Stein discusses the results of a groundbreaking open-label extension, which indicates the efficacy and safety of this investigative oral PCSK9 inhibitor.
November 20, 2025
Bhatt discusses the positive results from the phase 2 trial of quarterly and monthly doses of investigational IL-6 inhibitor pacibekitug.
November 17, 2025
Le discusses the increased risk of mortality and major adverse cardiovascular events in patients with both PAD and AF.
November 16, 2025
Data from 4 of the most impactful trials presented at the American Heart Association Scientific Sessions 2025.
November 13, 2025
Podcast
Discover groundbreaking insights from ASN Kidney Week on the SURPASS-CVOT trial.
